Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Donninger

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Molecular & Cellular Oncology|June 18, 2016
Nore1a drives Ras to flick the P53 senescence switchHoward Donninger, Geoffrey J Clark
Molecular Biology International|June 14, 2012
Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to ChemotherapyJennifer Clark, Jessica Freeman, Howard Donninger
The Journal of Biological Chemistry|December 18, 2015
Ras Regulates Rb via NORE1AThibaut Barnoud, Howard Donninger, Geoffrey J Clark
Cell Cycle (Georgetown, Tex.)|February 27, 2016
NORE1A is a double barreled Ras senescence effector that activates p53 and RbHoward Donninger, Thibaut Barnoud, Geoffrey J Clark
Journal of Cell Science|September 20, 2007
The RASSF1A tumor suppressorHoward Donninger, Michele D Vos, Geoffrey J Clark
Frontiers in Immunology|August 9, 2020
Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the EnvelopeChi Li, Howard Donninger, John Eaton, et al.
The Journal of Biological Chemistry|September 14, 2014
Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1AM Lee Schmidt, Howard Donninger, Geoffrey J Clark
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Detection of Endogenous RASSF1A Interacting ProteinsHoward Donninger, Desmond Harrell-Stewart, Geoffrey J Clark
Biological Chemistry|December 22, 2007
Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cellsHoward Donninger, Anke Binder, Lothar Bohm, et al.
Vaccines|July 2, 2021
Cancer Vaccines: Promising Therapeutics or an Unattainable DreamHoward Donninger, Chi Li, John W Eaton, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Molecular & Cellular Oncology|June 18, 2016
Nore1a drives Ras to flick the P53 senescence switchHoward Donninger, Geoffrey J Clark
Molecular Biology International|June 14, 2012
Loss of RASSF2 Enhances Tumorigencity of Lung Cancer Cells and Confers Resistance to ChemotherapyJennifer Clark, Jessica Freeman, Howard Donninger
The Journal of Biological Chemistry|December 18, 2015
Ras Regulates Rb via NORE1AThibaut Barnoud, Howard Donninger, Geoffrey J Clark
Cell Cycle (Georgetown, Tex.)|February 27, 2016
NORE1A is a double barreled Ras senescence effector that activates p53 and RbHoward Donninger, Thibaut Barnoud, Geoffrey J Clark
Journal of Cell Science|September 20, 2007
The RASSF1A tumor suppressorHoward Donninger, Michele D Vos, Geoffrey J Clark
Frontiers in Immunology|August 9, 2020
Regulatory Role of Immune Cell-Derived Extracellular Vesicles in Cancer: The Message Is in the EnvelopeChi Li, Howard Donninger, John Eaton, et al.
The Journal of Biological Chemistry|September 14, 2014
Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1AM Lee Schmidt, Howard Donninger, Geoffrey J Clark
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Detection of Endogenous RASSF1A Interacting ProteinsHoward Donninger, Desmond Harrell-Stewart, Geoffrey J Clark
Biological Chemistry|December 22, 2007
Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cellsHoward Donninger, Anke Binder, Lothar Bohm, et al.
Vaccines|July 2, 2021
Cancer Vaccines: Promising Therapeutics or an Unattainable DreamHoward Donninger, Chi Li, John W Eaton, et al.
Pageof 5